This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Wedbush analyst David Nierengarten initiated coverage on Telix Pharmaceuticals Limited TLX with an Outperform rating and announced a price target of $22. Telix Pharmaceuticals shares closed at $17.48 on Wednesday. See how other analysts view this stock.
Jefferies analyst Emma Schwartz initiated coverage on Excelerate Energy, Inc. EE with a Buy rating and announced a price target of $39. Excelerate Energy shares closed at $29.69 on Wednesday. See how other analysts view this stock.
Craig-Hallum analyst Albert Lowe initiated coverage on Atossa Therapeutics, Inc. ATOS with a Buy rating and announced a price target of $4. Atossa Therapeutics shares closed at $0.8571 on Wednesday. See how other analysts view this stock.
Morgan Stanley analyst Joshua Pokrzywinski initiated coverage on Parker-Hannifin Corporation PH with an Equal-Weight rating and announced a price target of $700. Parker Hannifin shares closed at $665.26 on Wednesday. See how other analysts view this stock.
Roth Capital analyst Boobalan Pachaiyappan initiated coverage on PolyPid Ltd. PYPD with a Buy rating and announced a price target of $9. PolyPid shares closed at $2.98 on Wednesday. See how other analysts view this stock.